Proteomics-Based Assays To Enable Precision Medicine For Ovarian Cancer

Pei Wang

Press/Media

Period	21 Sep 2023

Media coverage

1

Media coverage

Title	Proteomics-Based Assays To Enable Precision Medicine For Ovarian Cancer
Media name/outlet	Bio-IT World
Country/Territory	United States
Date	21/09/23
URL	ct.moreover.com/?a=51858633712&p=1gw&v=1&x=SeMXZTUnM_oPdu7ZNR2icA
Persons	Pei Wang

Related content

Publications & Research Outputs
A highly annotated database of genes associated with platinum resistance in cancer
Research output: Contribution to journal › Review article › peer-review
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Research output: Contribution to journal › Article › peer-review
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer
Research output: Contribution to journal › Article › peer-review